コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nsidered in the workup of neonatal hemolytic uremic syndrome.
2 ienced fatal chronic rejection and hemolytic uremic syndrome.
3 kinase epsilon result in atypical hemolytic-uremic syndrome.
4 c thrombocytopenic purpura and the hemolytic uremic syndrome.
5 causes severe bloody diarrhea and hemolytic uremic syndrome.
6 ar degeneration (AMD) and atypical hemolytic uremic syndrome.
7 r and renal injury and can trigger hemolytic uremic syndrome.
8 re hospitalized and 6.4% developed hemolytic uremic syndrome.
9 renal diseases, including atypical hemolytic uremic syndrome.
10 ribed in association with atypical hemolytic uremic syndrome.
11 mbomicroangiopathy called atypical hemolytic uremic syndrome.
12 hagic colitis and life-threatening hemolytic uremic syndrome.
13 es such as hemorrhagic colitis and hemolytic-uremic syndrome.
14 microangiopathy disease, atypical hemolytic uremic syndrome.
15 ers' diarrhea, gastroenteritis and hemolytic uremic syndrome.
16 re clinical manifestations such as hemolytic-uremic syndrome.
17 (EHEC) causes bloody diarrhea and hemolytic-uremic syndrome.
18 diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome.
19 (pathological) effects, including hemolytic uremic syndrome.
20 nteritis, hemorrhagic colitis, and hemolytic uremic syndrome.
21 in complement regulation, such as hemolytic uremic syndrome.
22 coli cause hemorrhagic colitis and hemolytic uremic syndrome.
23 Three patients had reversible hemolytic uremic syndrome.
24 causes hemorrhagic colitis and the hemolytic uremic syndrome.
25 agic colitis, and life-threatening hemolytic uremic syndrome.
26 n cases of hemorrhagic colitis and hemolytic uremic syndrome.
27 coincidental with the symptoms of hemolytic uremic syndrome.
28 actic or therapeutic agent against hemolytic-uremic syndrome.
29 gic colitis and, less commonly, to hemolytic-uremic syndrome.
30 f CD46 is a predisposing factor to hemolytic uremic syndrome.
31 e and the life-threatening sequela hemolytic uremic syndrome.
32 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
33 turnal hemoglobinuria and atypical hemolytic uremic syndrome.
34 ulation and thrombosis observed in hemolytic uremic syndrome.
35 ia coli (STEC) are associated with hemolytic uremic syndrome.
36 ey failure in children who develop hemolytic uremic syndrome.
37 diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome.
38 hospitalized and 2 (9%) developed hemolytic-uremic syndrome.
39 mortality among patients with the hemolytic-uremic syndrome.
40 ings in a four-month-old male with hemolytic uremic syndrome.
41 y sera from patients with atypical hemolytic uremic syndrome.
42 sy of a child with EHEC-associated hemolytic uremic syndrome.
43 luding hemorrhagic colitis and the hemolytic uremic syndrome.
44 s the cause of bloody diarrhea and hemolytic-uremic syndrome.
45 infections, as well as sepsis and hemolytic uremic syndrome.
46 s, such as hemorrhagic colitis and hemolytic uremic syndrome.
47 en causing hemorrhagic colitis and hemolytic uremic syndrome.
48 and disseminated malignancy or in hemolytic uremic syndrome.
49 litis that sometimes progresses to hemolytic-uremic syndrome.
50 izumab after a relapse of atypical hemolytic uremic syndrome.
51 erleukin-1beta, has been linked to hemolytic uremic syndrome.
52 hat causes hemorrhagic colitis and hemolytic uremic syndrome.
53 an experimental model for atypical hemolytic uremic syndrome.
54 O157 strains (P = 0.03) developing hemolytic-uremic syndrome.
55 ology of neuronal complications in hemolytic-uremic syndrome.
56 function in patients with atypical hemolytic-uremic syndrome.
57 evelopment of the life-threatening hemolytic uremic syndrome.
58 vein thrombosis (1), priapism (1), hemolytic uremic syndrome (1), diaphragm perforation (2), colonic
59 ve been reported--3167 without the hemolytic-uremic syndrome (16 deaths) and 908 with the hemolytic-u
60 drome (16 deaths) and 908 with the hemolytic-uremic syndrome (34 deaths)--indicating that this strain
62 FH and MCP are linked to atypical hemolytic uremic syndrome, a type of thrombotic microangiopathy (T
63 ent of colitis and/or signs of the hemolytic uremic syndrome after oral infection with Escherichia co
65 ns predispose patients to atypical hemolytic uremic syndrome (aHUS) and other disorders arising from
67 therapy in patients with atypical hemolytic uremic syndrome (aHUS) are remarkable in contrast to the
68 een well characterized in atypical hemolytic uremic syndrome (aHUS) but have been less well described
70 assay that could convert atypical hemolytic uremic syndrome (aHUS) from a diagnosis of exclusion int
71 shares similarities with atypical hemolytic uremic syndrome (aHUS) in the underlying pathomechanisms
89 mplement C3 identified in atypical hemolytic uremic syndrome (aHUS) patients cause dysregulation in t
90 tic microangiopathy (TMA) atypical hemolytic uremic syndrome (aHUS) resulted in the successful introd
91 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) strongly associate with inherited
92 of ADAMTS13 activity, and atypical hemolytic uremic syndrome (aHUS), a disease of complement overacti
93 escribed in patients with atypical hemolytic uremic syndrome (aHUS), a rare condition characterized b
95 ribed in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-re
96 cular degeneration (AMD), atypical hemolytic uremic syndrome (aHUS), and membranoproliferative glomer
97 reportedly contribute to atypical hemolytic uremic syndrome (aHUS), but incomplete penetrance sugges
99 ereas R53H-CFH, linked to atypical hemolytic uremic syndrome (aHUS), was defective in C3bBb decay-acc
100 nt dysregulation leads to atypical hemolytic uremic syndrome (aHUS), while ADAMTS13 deficiency causes
105 renal diseases, including atypical hemolytic uremic syndrome and C3 glomerulopathies, and age-related
106 postdiarrheal sequelae, including hemolytic uremic syndrome and central nervous system (CNS) abnorma
108 d with the renal diseases atypical hemolytic uremic syndrome and dense deposit disease and the ocular
110 vere disease, as defined by higher hemolytic uremic syndrome and hospitalization frequencies, suggest
111 implicated in the pathogenesis of hemolytic uremic syndrome and its attendant endothelial cell (EC)
113 iated endothelial damage: atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
115 implicated previously in atypical hemolytic uremic syndrome, and it abrogates C-terminal ligand bind
116 diseases such as AMD and atypical hemolytic uremic syndrome, and leads to a better understanding of
119 emic lupus erythematosus, atypical hemolytic uremic syndrome, and the complocentric membranoglomerulo
120 es have been described in atypical hemolytic uremic syndrome, arising commonly through nonallelic hom
121 of clinical presentation (atypical hemolytic uremic syndrome as thrombotic microangiopathy), biopsy a
122 d with wild type FH19-20, atypical hemolytic uremic syndrome-associated mutants were less able to com
123 f the structural basis of familial hemolytic uremic syndrome, attributed to mutational disruption of
124 hemoglobinuria (PNH) and atypical hemolytic uremic syndrome, blocks the terminal complement pathway
125 d with E. coli O157:H7 progress to hemolytic uremic syndrome, but this figure may reach 50% if antibi
126 n (Stx) causes diarrhea-associated hemolytic uremic syndrome by damaging renal microvascular endothel
127 croangiopathies including atypical hemolytic uremic syndrome, C3 and C1q glomerulopathies, and preecl
128 large outbreak of diarrhea and the hemolytic-uremic syndrome caused by an unusual serotype of Shiga-t
129 eutrophilia is a characteristic of hemolytic uremic syndrome caused by Shiga toxin (Stx2)-producing E
130 Five patients had evidence of a hemolytic uremic syndrome concurrently with or after sirolimus tre
133 Cellular injury in post-diarrheal hemolytic-uremic syndrome (D+HUS) is related to shigatoxin (Stx) b
135 serious but completely reversible hemolytic-uremic syndrome developed during the second cycle of tre
139 ia coli causes diarrhea-associated hemolytic-uremic syndrome (DHUS), a severe renal thrombotic microa
141 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy and (2) to search for r
142 nticomplement therapy for atypical hemolytic uremic syndrome during pregnancy, and implications of th
144 ve or therapeutic ends, for use in hemolytic uremic syndrome-endemic areas or during future outbreaks
145 e have identified a large atypical hemolytic uremic syndrome family where a deletion has occurred thr
146 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome from 1964 to 2002 were reviewed (1) to d
147 serious long-term sequelae such as hemolytic uremic syndrome, Guillain-Barre syndrome and malnutritio
149 botic thrombocytopenic purpura and hemolytic-uremic syndrome, have been reported to have a drug-induc
150 t influence the risk of developing hemolytic uremic syndrome (HUS) after Escherichia coli O157:H7 inf
152 o comprised 64.3% of patients with hemolytic uremic syndrome (HUS) and 87.5% of patients who died (P
153 x2) responsible for development of hemolytic uremic syndrome (HUS) and acute kidney injury (AKI).
154 mage is one of the major causes of hemolytic uremic syndrome (HUS) and acute renal failure in childre
155 histomorphologic similarities with hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic pu
156 thrombotic microangiopathy are the hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic pu
157 thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are appropriately at the top of a
158 mbocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS) are both characterized by thromboc
159 :H7 causes hemorrhagic colitis and hemolytic uremic syndrome (HUS) by colonizing the gut mucosa and p
160 ypes associated with postdiarrheal hemolytic uremic syndrome (HUS) cases among children and adults in
161 a toxin 2 (Stx2) are isolated from hemolytic-uremic syndrome (HUS) cases more frequently than are str
166 n often lead to the development of hemolytic-uremic syndrome (HUS) in a small percentage of infected
167 rhea or developed life-threatening hemolytic uremic syndrome (HUS) in any of 6 closed cohorts from 4
168 ibes the epidemiology of childhood hemolytic uremic syndrome (HUS) in California, for which hospitali
169 sed an outbreak with >800 cases of hemolytic uremic syndrome (HUS) in Germany, including 90 children.
180 scherichia coli O157:H7-associated hemolytic-uremic syndrome (HUS) is characterized by profound proth
188 infection with a high incidence of hemolytic uremic syndrome (HUS) occurred in Germany in May 2011.
189 2011 the largest known outbreak of hemolytic uremic syndrome (HUS) occurred in northern Germany.
190 On 22 June 2011, 8 patients with hemolytic uremic syndrome (HUS) or bloody diarrhea were reported i
193 the 62 individuals with diarrheal hemolytic uremic syndrome (HUS) seen at our institution during the
194 g agent of postdiarrhea-associated hemolytic uremic syndrome (HUS), a disorder of glomerular ischemic
195 imary cause of diarrhea-associated hemolytic uremic syndrome (HUS), a disorder of thrombocytopenia, m
196 emorrhagic colitis and can lead to hemolytic-uremic syndrome (HUS), a life-threatening condition that
197 main etiological agent that causes hemolytic uremic syndrome (HUS), a microangiopathic disease charac
198 coli O157:H7 infection can lead to hemolytic-uremic syndrome (HUS), a severe disease characterized by
199 oody diarrhea that can progress to hemolytic uremic syndrome (HUS), a systematic microvascular syndro
200 cytotoxic proteins that can cause hemolytic-uremic syndrome (HUS), a thrombotic microangiopathy, fol
201 s, the development and severity of hemolytic uremic syndrome (HUS), and adverse outcomes in STEC-infe
202 trains are responsible for causing hemolytic-uremic syndrome (HUS), and systemic administration of Sh
204 es to hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS), due to the expression of one or m
206 ative pathway, are associated with hemolytic uremic syndrome (HUS), membranoproliferative glomerulone
207 e pathogenesis of postenteropathic hemolytic uremic syndrome (HUS), most commonly caused by Shiga tox
209 h as sickle cell disease (SCD) and hemolytic uremic syndrome (HUS), pathological biophysical interact
210 n STEC isolates from patients with hemolytic-uremic syndrome (HUS), patients with less severe diarrhe
212 b pasudotox for 10 doses developed hemolytic uremic syndrome (HUS), thrombotic microangiopathy (TMA),
214 uding hemorrhagic colitis (HC) and hemolytic-uremic syndrome (HUS), which is the most common cause of
215 effects of STEC infection, such as hemolytic-uremic syndrome (HUS), zinc might be capable of preventi
243 a cause of food-borne colitis and hemolytic-uremic syndrome in children, can be serotype O157:H7 (O1
246 toxin-producing E. coli-associated hemolytic uremic syndrome in six hospitals in Hamburg, Germany, be
248 l outbreaks of bloody diarrhea and hemolytic-uremic syndrome in the United States and worldwide.
250 ed mice developed the hallmarks of hemolytic uremic syndrome, including thrombotic microangiopathy, h
255 and autoantibody-positive form of hemolytic uremic syndrome is characterized by the presence of auto
256 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome is near term and during the postpartum p
261 2), one of the causative agents of hemolytic-uremic syndrome, is toxic to endothelial cells, includin
264 more frequent with everolimus and hemolytic uremic syndrome, lymphoproliferative disease, and protei
265 ng sequela of infection called the hemolytic uremic syndrome may develop that can lead to kidney fail
266 157:H7 causes severe enteritis and hemolytic-uremic syndrome, mostly in young children and older adul
267 us toxicity was reversible grade 3 hemolytic uremic syndrome, not requiring plasmapheresis, in two pa
269 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome occurs more commonly in women and among
270 ive regulation of the AP (atypical hemolytic-uremic syndrome) or with inadequate cleavage by ADAMTS-1
271 y-confirmed E coli O157 infection, hemolytic-uremic syndrome, or bloody diarrhea within 7 days of att
273 toxin-producing E. coli-associated hemolytic uremic syndrome outbreak in Germany, critical illness de
274 om 19 anti-FH Ab-positive atypical hemolytic uremic syndrome patients collected at the acute phase of
276 ults may also explain why atypical hemolytic uremic syndrome patients with mutations affecting domain
277 pathophysiology and progression to hemolytic uremic syndrome provides the basis for prevention, proph
281 ted with the related human disease hemolytic uremic syndrome) resulted in a striking syndrome closely
282 February 2001 using the key words hemolytic uremic syndrome, risk factor, antibiotics, and Escherich
283 treptococcus pneumoniae associated hemolytic uremic syndrome (SpHUS) is defined by the occurrence of
287 of rare diseases such as atypical hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, C3
289 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is difficult because of lack o
290 hrombotic thrombocytopenia purpura/hemolytic uremic syndrome (TTP/HUS) case involved a patient who un
291 treatment guidelines for atypical hemolytic uremic syndrome was held in Bergamo in December 2007.
293 ns similar to those in humans with hemolytic-uremic syndrome were observed histologically in 82 of 12
295 ls in which patients with atypical hemolytic-uremic syndrome who were 12 years of age or older receiv
296 hrombotic thrombocytopenic purpura-hemolytic uremic syndrome who were initially diagnosed during thei
298 ormalities consistent with grade 2 hemolytic uremic syndrome with peak creatinine of 1.53 to 1.66 mg/
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。